Bristol Myers Squibb is a differentiated company, led by our revolutionary BioPharma strategy that combines the reach and resources of a major pharmaceutical firm with the entrepreneurial flair and swiftness of a biotech business. We strive to provide advanced medications for people struggling from life-threatening illnesses each and every day. Each day, our employees around the world work together for patients - it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, haematology, cardiology, immunology, fibrosis, and specialty medicines. Through our Research & Development organisation, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work. As global citizens, we operate in a responsible and sustainable manner and search for ways to give back. Through the Bristol Myers Squibb Foundation, we promote health equity and attempt to improve health outcomes of those disproportionately affected by severe illnesses, bringing new hope to some of the most vulnerable people across the globe.